Cargando…
Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two devastating human neurodegenerative diseases. A hallmark pathological feature of both diseases is the depletion of the RNA‐binding protein TDP‐43 from the nucleus in the brain and spinal cord of patients. A major function...
Autores principales: | Akiyama, Tetsuya, Koike, Yuka, Petrucelli, Leonard, Gitler, Aaron D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098226/ https://www.ncbi.nlm.nih.gov/pubmed/35567447 http://dx.doi.org/10.1002/ctm2.818 |
Ejemplares similares
-
CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia
por: Williams, Kelly L., et al.
Publicado: (2016) -
Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia
por: Schymick, Jennifer C, et al.
Publicado: (2012) -
Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
por: Deng, Zhiqiang, et al.
Publicado: (2017) -
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020) -
The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Abramzon, Yevgeniya A., et al.
Publicado: (2020)